ZOOZ Strategy Ltd.

What they do

ZOOZ Strategy Ltd. is an Israeli company whose ordinary shares and warrants trade on the Nasdaq Capital Market under ZOOZ and ZOOZW. Its SEC filing is a Form 20-F for fiscal year 2025 prepared under U.S. GAAP and presented in U.S. dollars. The excerpts provided identify the registrant, its securities, contact details and filing framework but do not describe its products, services or customers.

Revenue drivers

• Principal business operations — Revenue is not broken out by segment in the excerpts; total annual revenue was $0.764 million in 2023, $1.0 million in 2024 and $0.247 million in 2025.
• Reported product or service lines — The filing excerpts provided do not name specific products, services or customers, so no individual revenue line can be sized or described.

Recent performance

Total revenue was $0.247 million in 2025, down from $1.0 million in 2024 and $0.764 million in 2023. Net loss was $55.6 million in 2025, compared with $11.0 million in 2024 and $11.8 million in 2023. Diluted EPS was negative $0.94 in 2025, versus negative $1.09 in 2024 and negative $1.99 in 2023. Operating cash flow was negative $13.8 million in 2025, after negative $9.9 million in 2024 and negative $12.2 million in 2023. At December 31, 2025, the company reported total assets of $122.6 million, total liabilities of $3.4 million, shareholder equity of $119.2 million, and cash and equivalents of $27.0 million.

Strategy

The excerpt provided from Item 1 states the company is ZOOZ Strategy Ltd., an Israeli company whose ordinary shares and warrants are listed on the Nasdaq Capital Market. It does not describe management's stated strategy, investment plans or priorities. No strategy details can be summarized from the excerpts supplied.

Risks

• Revenue concentration or volatility — Revenue fell from $1.0 million in 2024 to $0.247 million in 2025, a decline of roughly 75%.
• Persistent losses — Net loss widened to $55.6 million in 2025 from $11.0 million in 2024.
• Negative operating cash flow — Operating cash flow was negative $13.8 million in 2025, the fourth consecutive year of negative operating cash flow shown.
• Limited business disclosure in the excerpt — The Item 1 and Item 7 text provided does not identify specific products, customers, contracts or risk factors beyond the company's identity and listing.

Outlook

The excerpts provided do not contain management's outlook, guidance or forward-looking financial targets. Accordingly, no outlook statement can be summarized from the source material. The only year-end data available is the December 31, 2025 balance sheet showing $27.0 million of cash and equivalents and $119.2 million of shareholder equity.